EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine

Jelena Dinić iD, Sofija Jovanović Stojanov iD, Miodrag Dragoj iD, Marija Grozdanić iD, Ana Podolski-Renić iD, Milica Pešić iD

Life · 10.09.2024 · 14 (9) · 1142

DOI: 10.3390/life14091142 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 10.09.2024. Verfasst von Jelena Dinić und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade…. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 263 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Fund of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The field of oncology has witnessed remarkable progress in personalized cancer therapy. Functional precision medicine has emerged as a promising avenue for achieving superior treatment outcomes by integrating omics profiling and sensitivity testing of patient-derived cancer cells. This review paper provides an in-depth analysis of the evolution of cancer-directed drugs, resistance mechanisms, and the role of functional precision medicine platforms in revolutionizing individualized treatment strategies. Using two-dimensional (2D) and three-dimensional (3D) cell cultures, patient-derived xenograft (PDX) models, and advanced functional assays has significantly improved our understanding of tumor behavior and drug response. This progress will lead to identifying more effective treatments for more patients. Considering the limited eligibility of patients based on a genome-targeted approach for receiving targeted therapy, functional precision medicine provides unprecedented opportunities for customizing medical interventions according to individual patient traits and individual drug responses. This review delineates the current landscape, explores limitations, and presents future perspectives to inspire ongoing advancements in functional precision medicine for personalized cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

anticancer drugsdrug resistancefunctional assaysfunctional precision medicinetargeted therapy

Autor:innen und Institutionen

  • Department of Neurobiology, Institute for Biological Research "Siniša Stanković"-National Institute of the Republic of Serbia, University of Belgrade, Bulevar Despota Stefana 142, 11108 Belgrade, Serbia.

ORCID-Profile: Jelena Dinić, Sofija Jovanović Stojanov, Miodrag Dragoj, Marija Grozdanić, Ana Podolski-Renić, Milica Pešić

Förderung

  • Science Fund of the Republic of Serbia

Zitieren

APA

Dinić, J., Jovanović Stojanov, S., Dragoj, M., Grozdanić, M., Podolski-Renić, A., & Pešić, M. (2024). Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine. Life, 14(9), 1142. https://doi.org/10.3390/life14091142

Vancouver

Dinić J, Jovanović Stojanov S, Dragoj M, Grozdanić M, Podolski-Renić A, Pešić M. Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine. Life. 2024;14(9):1142. doi:10.3390/life14091142

BibTeX
@article{Dini2024,
  author = {Dinić, Jelena and Jovanović Stojanov, Sofija and Dragoj, Miodrag and Grozdanić, Marija and Podolski-Renić, Ana and Pešić, Milica},
  title = {Cancer Patient-Derived Cell-Based Models: Applications and Challenges in Functional Precision Medicine},
  journal = {Life},
  year = {2024},
  volume = {14},
  number = {9},
  pages = {1142},
  doi = {10.3390/life14091142}
}
Kostenlos starten →